EnWave Corporation reported that it has been added to The Cannabis ETF (NYSE:THCX) (“THCX”) which trades on the New York Stock Exchange. THCX follows the Innovation Labs Cannabis Index, which is a portfolio of 35 holdings expected to benefit from growth of the legal marijuana, CBD and hemp industries.
Mr. Brent Charleton, President and CEO of EnWave Corporation, remarks. “We’re excited about the access this fund provides for U.S. based investors. We’re proud of the progress we’ve made with our proprietary REV™ technology in the legal cannabis sector and we will continue to work towards securing partners in this rapidly growing sector.”
EnWave currently has three royalty-bearing commercial license agreements with Canadian cannabis companies and one royalty-bearing commercial license agreement with a hemp producer in the United States.
On June 3, 2019, EnWave was added to the Horizon Marijuana Life Sciences Index ETF (TSX:HMMJ) (“HMMJ”). HMMJ is the world’s first ETF offering direct exposure to North American-listed securities that are involved with marijuana bioengineering and production. HMMJ has added additional companies to its portfolio as more firms have become eligible for inclusion in its underlying index – the North American Marijuana Index.
For more information on The Cannabis ETF (NYSE:THCX), please visit: https://thcxetf.com and https://thcxetf.com/2019/08/13/the-cannabis-etf-thcx-rebalance-further-diversifies-portfolio/.
For more information on Horizon Marijuana Life Sciences Index ETF (TSX:HMMJ), please visit: https://www.horizonsetfs.com/hmmj.